E. Berger, P. Murphy, and J. Farber, CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease, Annual Review of Immunology, vol.17, issue.1, pp.657-700, 1999.
DOI : 10.1146/annurev.immunol.17.1.657

P. Dorr, M. Westby, S. Dobbs, P. Griffin, B. Irvine et al., Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, pp.4721-4732, 2005.
DOI : 10.1128/AAC.49.11.4721-4732.2005

S. Raymond, P. Delobel, M. Mavigner, M. Cazabat, C. Souyris et al., Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage, Journal of Clinical Virology, vol.47, issue.2, pp.126-130, 2010.
DOI : 10.1016/j.jcv.2009.11.018

V. Trouplin, F. Salvatori, F. Cappello, V. Obry, A. Brelot et al., Determination of Coreceptor Usage of Human Immunodeficiency Virus Type 1 from Patient Plasma Samples by Using a Recombinant Phenotypic Assay, Journal of Virology, vol.75, issue.1, pp.251-259, 2001.
DOI : 10.1128/JVI.75.1.251-259.2001

J. Whitcomb, W. Huang, S. Fransen, K. Limoli, J. Toma et al., Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism, Antimicrobial Agents and Chemotherapy, vol.51, issue.2, pp.566-575, 2007.
DOI : 10.1128/AAC.00853-06

P. Recordon-pinson, C. Soulie, P. Flandre, D. Descamps, M. Lazrek et al., Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study, Antimicrobial Agents and Chemotherapy, vol.54, issue.8, pp.3335-3340, 2010.
DOI : 10.1128/AAC.00148-10
URL : https://hal.archives-ouvertes.fr/hal-00594694

E. Seclen, C. Garrido, G. Mdel, M. Gonzalez-lahoz, J. De-mendoza et al., High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists, Journal of Antimicrobial Chemotherapy, vol.65, issue.7, pp.1486-1492, 2010.
DOI : 10.1093/jac/dkq137

P. Delobel, M. Nugeyre, M. Cazabat, C. Pasquier, B. Marchou et al., Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies, Journal of Clinical Microbiology, vol.45, issue.5, pp.1572-1580, 2007.
DOI : 10.1128/JCM.02090-06

C. Garrido, V. Roulet, N. Chueca, E. Poveda, A. Aguilera et al., Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes, Journal of Clinical Microbiology, vol.46, issue.3, pp.887-891, 2008.
DOI : 10.1128/JCM.01611-07

S. Raymond, P. Delobel, M. Mavigner, M. Cazabat, C. Souyris et al., Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism, AIDS, vol.22, issue.14, pp.11-16, 2008.
DOI : 10.1097/QAD.0b013e32830ebcd4

S. Raymond, P. Delobel, M. Mavigner, M. Cazabat, C. Souyris et al., Genotypic Prediction of Human Immunodeficiency Virus Type 1 CRF02-AG Tropism, Journal of Clinical Microbiology, vol.47, issue.7, pp.2292-2294, 2009.
DOI : 10.1128/JCM.02439-08

S. Raymond, P. Delobel, M. Mavigner, L. Ferradini, M. Cazabat et al., Prediction of HIV Type 1 Subtype C Tropism by Genotypic Algorithms Built From Subtype B Viruses, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.53, issue.2, pp.167-175, 2010.
DOI : 10.1097/QAI.0b013e3181c8413b

B. Taylor and S. Hammer, The Challenge of HIV-1 Subtype Diversity, New England Journal of Medicine, vol.359, issue.18, pp.1965-1966, 2008.
DOI : 10.1056/NEJMc086373

J. Baeten, B. Chohan, L. Lavreys, V. Chohan, R. Mcclelland et al., HIV???1 Subtype D Infection Is Associated with Faster Disease Progression than Subtype A in Spite of Similar Plasma HIV???1 Loads, The Journal of Infectious Diseases, vol.195, issue.8, pp.1177-1180, 2007.
DOI : 10.1086/512682

P. Easterbrook, M. Smith, J. Mullen, O. Shea, S. Chrystie et al., Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy, Journal of the International AIDS Society, vol.13, issue.1, p.4, 2010.
DOI : 10.1186/1758-2652-13-4

P. Kaleebu, N. French, C. Mahe, D. Yirrell, C. Watera et al., Effect of Human Immunodeficiency Virus (HIV) Type 1 Envelope Subtypes A and D on Disease Progression in a Large Cohort of HIV???1???Positive Persons in Uganda, The Journal of Infectious Diseases, vol.185, issue.9, pp.1244-1250, 2002.
DOI : 10.1086/340130

N. Kiwanuka, M. Robb, O. Laeyendecker, G. Kigozi, F. Wabwire-mangen et al., HIV-1 Viral Subtype Differences in the Rate of CD4+ T-Cell Decline Among HIV Seroincident Antiretroviral Naive Persons in Rakai District, Uganda, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.54, pp.180-184, 2010.
DOI : 10.1097/QAI.0b013e3181c98fc0

A. Vasan, B. Renjifo, E. Hertzmark, B. Chaplin, G. Msamanga et al., Different Rates of Disease Progression of HIV Type 1 Infection in Tanzania Based on Infecting Subtype, Clinical Infectious Diseases, vol.42, issue.6, pp.843-852, 2006.
DOI : 10.1086/499952

J. Church, W. Huang, A. Mwatha, J. Toma, E. Stawiski et al., HIV???1 Tropism and Survival in Vertically Infected Ugandan Infants, The Journal of Infectious Diseases, vol.197, issue.10, pp.1382-1388, 2008.
DOI : 10.1086/587492

W. Huang, S. Eshleman, T. J. Fransen, S. Stawiski, E. Paxinos et al., Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations, Journal of Virology, vol.81, issue.15, pp.7885-7893, 2007.
DOI : 10.1128/JVI.00218-07

P. Kaleebu, I. Nankya, D. Yirrell, L. Shafer, J. Kyosiimire-lugemwa et al., Relation Between Chemokine Receptor Use, Disease Stage, and HIV-1 Subtypes A and D, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.45, issue.1, pp.28-33, 2007.
DOI : 10.1097/QAI.0b013e3180385aa0

D. Wolf, F. Hogervorst, E. Goudsmit, J. Fenyo, E. Rubsamen-waigmann et al., Syncytiuminducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and Raymond et al. Retrovirology, pp.56-56, 2011.

P. Zhong, M. Peeters, W. Janssens, K. Fransen, L. Heyndrickx et al., Correlation between Genetic and Biological Properties of Biologically Cloned HIV Type 1 Viruses Representing Subtypes A, B, and D, AIDS Research and Human Retroviruses, vol.11, issue.2, pp.239-248, 1995.
DOI : 10.1089/aid.1995.11.239

D. Jong, J. De-ronde, A. Keulen, W. Tersmette, M. Goudsmit et al., Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution, J Virol, vol.66, pp.6777-6780, 1992.

R. Fouchier, M. Groenink, N. Kootstra, M. Tersmette, H. Huisman et al., Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule, J Virol, vol.66, pp.3183-3187, 1992.

A. Saliou, P. Delobel, M. Dubois, F. Nicot, R. S. Calvez et al., Concordance between Two Phenotypic Assays and Ultradeep Pyrosequencing for Determining HIV-1 Tropism, Antimicrobial Agents and Chemotherapy, vol.55, issue.6, pp.2831-2836, 2011.
DOI : 10.1128/AAC.00091-11
URL : https://hal.archives-ouvertes.fr/hal-00675722

A. Carrillo and L. Ratner, Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells, J Virol, vol.70, pp.1310-1316, 1996.

S. Masciotra, S. Owen, D. Rudolph, C. Yang, B. Wang et al., Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression, AIDS, vol.16, issue.14, pp.1887-1898, 2002.
DOI : 10.1097/00002030-200209270-00005
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.667.8965

M. Groenink, A. Andeweg, R. Fouchier, S. Broersen, R. Van-der-jagt et al., Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain, J Virol, vol.66, pp.6175-6180, 1992.

A. Thielen, N. Sichtig, R. Kaiser, J. Lam, P. Harrigan et al., Improved Prediction of HIV???1 Coreceptor Usage with Sequence Information from the Second Hypervariable Loop of gp120, The Journal of Infectious Diseases, vol.202, issue.9, pp.1435-1443, 2010.
DOI : 10.1086/656600